HEALTH (MSM)

Mylan not relying on acquisitions if Perrigo bid fails: chairman

By Steven Scheer TEL AVIV (Reuters) – Mylan will likely win its bid to take over Irish-based generic drugmaker Perrigo Co, but if the bid fails the company can live without seeking an alternative acquisition, its chairman said on Wednesday. Mylan made an offer for Perrigo in April, which was rejected, and went hostile in September with its $25 billion all-share offer. Perrigo shareholders have until Nov. 13 to accept.

Amy Winehouse Documentary Depicts Addiction's Perfect Storm

I watched Amy, the Amy Winehouse documentary, yesterday. What an unbelievable spirit she was. What a beautiful and unique presence! The film’s depiction of the unfolding tragedy of her addiction haunted me through last night’s quasi-sleep. There was a moment in the doc where Amy has just won the Grammy Award for Best Song for “Rehab.”…

Amy Winehouse Documentary Depicts Addiction's Perfect Storm

I watched Amy, the Amy Winehouse documentary, yesterday. What an unbelievable spirit she was. What a beautiful and unique presence! The film’s depiction of the unfolding tragedy of her addiction haunted me through last night’s quasi-sleep. There was a moment in the doc where Amy has just won the Grammy Award for Best Song for “Rehab.”…

‘July phenomenon’ may not mean worse outcomes for surgeries

By Lisa Rapaport (Reuters Health) – The annual arrival each summer of a fresh crop of surgical residents and interns is not necessarily linked to worse outcomes for patients, a U.S. study suggests. Sometimes called the “July phenomenon,” this period has long been thought to be a time of year when patients might not fare as well due to the influx of less experienced clinicians, the study authors note in

‘July phenomenon’ may not mean worse outcomes for surgeries

By Lisa Rapaport (Reuters Health) – The annual arrival each summer of a fresh crop of surgical residents and interns is not necessarily linked to worse outcomes for patients, a U.S. study suggests. Sometimes called the “July phenomenon,” this period has long been thought to be a time of year when patients might not fare as well due to the influx of less experienced clinicians, the study authors note in

British cancer drugs fund changes tack: again

A British cancer drugs scheme, slammed as “stupid” by Roche’s chief executive two months ago, has undergone another about-turn, with some medicines dropped from coverage now being reinstated. The Cancer Drugs Fund (CDF), which helps patients receive cancer drugs not routinely paid for by the National Health Service (NHS), said on Wednesday that some drugs would remain available after further price negotiations with manufacturers. “It’s great news that some drugs

British cancer drugs fund changes tack: again

A British cancer drugs scheme, slammed as “stupid” by Roche’s chief executive two months ago, has undergone another about-turn, with some medicines dropped from coverage now being reinstated. The Cancer Drugs Fund (CDF), which helps patients receive cancer drugs not routinely paid for by the National Health Service (NHS), said on Wednesday that some drugs would remain available after further price negotiations with manufacturers. “It’s great news that some drugs

GSK plan to file up to 20 new drugs by 2020 underwhelms market

By Ben Hirschler LONDON (Reuters) – GlaxoSmithKline could file up to 20 new drugs for regulatory approval before 2020 as it seeks to revitalize a portfolio hit by falling sales of best-selling inhaled lung treatment Advair, the company said on Tuesday. The company highlighted projects in six core areas: HIV and other infections, respiratory medicine, oncology, immuno-inflammation, vaccines and rare diseases. Chief Executive Andrew Witty said around 80 percent of

Confusion about introducing solid foods to babies, survey finds

By Daniel Gaitan (Reuters Health) – A recent survey found many parents are unsure about when and how to best introduce solid foods to babies. According to a survey of 200 parents and expecting parents conducted by Beech-Nut Nutrition Company, more than half (53 percent) think information available on infant nutrition is not clear. One-third (34 percent) admit they are not sure when they should start their infant on solid

To tackle jihadis, French activist says, ditch reason

By Pauline Mevel and Chine Labbé PARIS (Reuters) – Anthropologist Dounia Bouzar used to try religious arguments to turn young people away from militant Islam – and failed. “Characteristically, a young person who has been recruited … thinks that he is chosen and that he knows the truth,” said the bleach-blond, discreetly watched by three police bodyguards as she sat in a Parisian café. “As soon as you use reason